Lianyungang, China

Zhulian Jiang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Zhulian Jiang

Introduction

Zhulian Jiang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical use. His work focuses on innovative solutions for treating serious health conditions.

Latest Patents

Zhulian Jiang holds a patent for an Azetidine derivative. This patent discloses a compound represented by a specific formula, along with its pharmaceutically acceptable salts, tautomers, stereoisomers, and geometrical isomers. The compound is particularly useful in the preparation of drugs aimed at treating or preventing multiple myeloma, a type of cancer that affects plasma cells.

Career Highlights

Throughout his career, Zhulian Jiang has worked with prominent companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he has contributed to various projects and innovations. His expertise in drug development has made him a valuable asset in the field.

Collaborations

Zhulian Jiang has collaborated with several professionals in his field, including Jian Xiong and Cheng Xie. These collaborations have further enhanced his research and development efforts, leading to advancements in pharmaceutical innovations.

Conclusion

Zhulian Jiang's contributions to the pharmaceutical industry, particularly through his patent for an Azetidine derivative, highlight his role as an innovative inventor. His work continues to impact the development of treatments for serious health conditions, showcasing the importance of research and collaboration in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…